Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

Table 1 Geographical distribution of GIPAP active¹ participating patients, 2007

Continent	Population²	Number of active CML patients	% of population active
Asia	3,461,233,811	14,927	0.0004%
Africa	643,500,700	1,201	0.0002%
Latin America	371,975,205	1,370	0.0004%
Europe	245,085,256	509	0.0002%
Oceania	839,000	7	0.0008%
Total	4,722,633,972	18,004

Note: ¹ If the number of non-active patients is added, the total number of patients participating in the program reaches 26,532.
² Population figures are related to participating countries only.
Source: The authors from the GIPAP database.

ISSN: 1744-8603